Abreos Biosciences
company
About
Abreos Biosciences develops lateral flow assays that measure the activity of high value biologics.
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $725K
- Industries
- Biotechnology,Clinical Trials,Medical
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Abreos Biosciences develops lateral flow assays that measure the activity of high-value biologics. Its simple devices can be used for quality assurance, pharmacokinetic monitoring, and authentication in field, forensic, or point of care settings. We deliver value by enhancing brand protection, improving patients’ outcomes, and enabling rapid authentication for counterfeit prevention and end-user confidence. The company was founded in 2013 and headquartered in San Diego, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.92M
Abreos Biosciences has raised a total of
$1.92M
in funding over 2 rounds. Their latest funding was raised on
Jun 5, 2017 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 5, 2017 | Debt Financing | $1.20M | 1 | — | — | Detail |
| Jul 13, 2016 | Seed | $725K | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Abreos Biosciences is funded by 1 investors.
Triton Technology Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
